Pilgrim’s Pride Announces Senior Unsecured Notes Offering
Sep 25, 2017 11:28 am UTC| Business
GREELEY, Colo., Sept. 25, 2017 -- Pilgrim’s Pride Corporation (NASDAQ:PPC) (the “Company”) announced today that it is offering, subject to market conditions, two series of senior unsecured notes, consisting of...
Mesoblast Presents Corporate Updates at Global Healthcare Conferences
Sep 25, 2017 11:27 am UTC| Business
NEW YORK and MELBOURNE, Australia, Sept. 25, 2017 -- Mesoblast Limited (Nasdaq:MESO) (ASX:MSB) today announced that the company will this week present corporate updates at the annual Cantor Fitzgerald Global Healthcare...
Sep 25, 2017 11:15 am UTC| Business
Houston, Sept. 25, 2017 -- Noble Energy, Inc. (NYSE: NBL) (“Noble Energy” or “the Company”) today provided an updated outlook for the third quarter of 2017. Sales volumes for the third quarter have been raised to...
Sep 25, 2017 11:05 am UTC| Business
NEW YORK, Sept. 25, 2017 -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver...
GSX Solutions Names Microsoft MVP Gary Steere New CTO
Sep 25, 2017 11:01 am UTC| Business
BOSTON, Sept. 25, 2017 -- GSX Solutions, the leading provider of monitoring and management solutions for messaging, collaboration, and mobility applications, today announced Gary Steere as new chief technology officer...
Intellipharmaceutics Receives Complete Response Letter from the FDA for Rexista™ NDA
Sep 25, 2017 11:00 am UTC| Business
TORONTO, Sept. 25, 2017 -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:IPCI) (“Intellipharmaceutics” or the “Company”), a pharmaceutical company specializing in the research, development and manufacture...
Sep 25, 2017 11:00 am UTC| Business
INDIANAPOLIS, Sept. 25, 2017 -- Assembly Biosciences, Inc. (NASDAQ:ASMB), a clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and...